Arcturus Therapeutics Holdings (ARCT) Change in Acquisitions & Divestments (2018)

Arcturus Therapeutics Holdings (ARCT) posted Change in Acquisitions & Divestments of -$5000.0 for Q4 2018, down 100.06% on a QoQ basis from $8.0 million in Q3 2018.

Arcturus Therapeutics Holdings (ARCT) Change in Acquisitions & Divestments (2018) Analysis & Trends

Arcturus Therapeutics Holdings' Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at -$5000.0 for Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,440.76 Bn 66,440.47 Bn -
2 Nanobiotix 1,909.20 Bn 1,909.14 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 468.28 Bn 463.49 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.49 Bn 115.24 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.26 Bn 61.51 Bn 3.31 Bn
7 Belite Bio 62.88 Bn 62.88 Bn -
8 Argenx Se 55.67 Bn 50.48 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn
10 Arcturus Therapeutics Holdings 161.00 Mn -50.37 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 -5,000.00
Dec 31, 2018 -5,000.00
Sep 30, 2018 7.96 Mn
Sep 30, 2018 7.96 Mn